- Home
- IBIO vs BFRG Comparison
IBIO vs BFRG Comparison
Compare IBIO & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBIO | BFRG |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 13.1M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | IBIO | BFRG |
|---|---|---|
| Price | $2.15 | $0.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 14.2M | 1.3M |
| Earning Date | 02-09-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | $116,670.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 185.71 | N/A |
| 52 Week Low | $0.56 | $0.80 |
| 52 Week High | $6.89 | $4.84 |
Technical Indicators
Market Signals| Indicator | IBIO | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 36.37 |
| Support Level | $1.82 | $0.86 |
| Resistance Level | $2.68 | $1.05 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 44.39 | 15.90 |
Price Performance
Historical ComparisonAbout IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.